Copyright © 2013 Neuza Mariko Aymoto Hassimotto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. A. Castaneda-Ovando, M. D. Pacheco-Hernandez, M. E. Paez-Hernandez, J. A. Rodríguez, and C. A. Galán-Vidal, “Chemical studies of anthocyanins: a review,” Food Chemistry, vol. 113, no. 4, pp. 859–871, 2009.
2. M. N. Clifford, “Anthocyanins- nature, occurrence and dietary burden,” Journal Science Food Agriculture, vol. 80, no. 7, pp. 1063–1072, 2000.
3. S. Pacifico, B. D'Abrosca, M. Scognamiglio et al., “Metabolic profiling of strawberry grape (Vitis × labruscana cv. “Isabella” components by nuclear magnetic resonance (NMR) and evaluation of their antioxidant and antiproliferative properties,” Journal of Agricultural and Food Chemistry, vol. 59, no. 14, pp. 7679–7687, 2011. View at Publisher · View at Google Scholar · View at Scopus
4. N. P. Seeram, L. S. Adams, Y. Zhang et al., “Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro,” Journal of Agricultural and Food Chemistry, vol. 54, no. 25, pp. 9329–9339, 2006. View at Publisher · View at Google Scholar · View at Scopus
5. P. N. Chen, S. C. Chu, H. L. Chiou, W. H. Kuo, C. L. Chiang, and Y. S. Hsieh, “Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line,” Cancer Letters, vol. 235, no. 2, pp. 248–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
6. T. Matsui, I. A. Ogunwande, K. J. M. Abesundara, and K. Matsumoto, “Anti-hyperglycemic potential of natural products,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 3, pp. 349–356, 2006. View at Publisher · View at Google Scholar · View at Scopus
7. T. Tsuda, F. Horio, K. Uchida, H. Aoki, and T. Osawa, “Dietary cyanidin 3-O-β-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice,” Journal of Nutrition, vol. 133, no. 7, pp. 2125–2130, 2003. View at Scopus
8. T. Tsuda, Y. Ueno, T. Yoshikawa, H. Kojo, and T. Osawa, “Microarray profiling of gene expression in human adipocytes in response to anthocyanins,” Biochemical Pharmacology, vol. 71, no. 8, pp. 1184–1197, 2006. View at Publisher · View at Google Scholar · View at Scopus
9. K. Wang, P. Jin, S. Cao, H. Shang, Z. Yang, and Y. Zheng, “Methyl jasmonate reduces decay and enhances antioxidant capacity in chinese bayberries,” Journal of Agricultural and Food Chemistry, vol. 57, no. 13, pp. 5809–5815, 2009. View at Publisher · View at Google Scholar · View at Scopus
10. C. Pergola, A. Rossi, P. Dugo, S. Cuzzocrea, and L. Sautebin, “Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract,” Nitric Oxide, vol. 15, no. 1, pp. 30–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
11. Y. P. Hwang, J. H. Choi, H. J. Yun et al., “Anthocyanins from purple sweet potato attenuate dimethylnitrosamine-induced liver injury in rats by inducing Nrf2-mediated antioxidant enzymes and reducing COX-2 and iNOS expression,” Food and Chemical Toxicology, vol. 49, no. 1, pp. 93–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
12. S. L. Yeh, H. M. Wang, P. Y. Chen, and T. C. Wu, “Interactions of β-carotene and flavonoids on the secretion of pro-inflammatory mediators in an in vitro system,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 386–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
13. J. M. Tall, N. P. Seeram, C. Zhao, M. G. Nair, R. A. Meyer, and S. N. Raja, “Tart cherry anthocyanins suppress inflammation-induced pain behavior in rat,” Behavioural Brain Research, vol. 153, no. 1, pp. 181–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
14. S. W. Min, S. N. Ryu, and D. H. Kim, “Anti-inflammatory effects of black rice, cyanidin-3-O-β-d-glycoside, and its metabolites, cyanidin and protocatechuic acid,” International Immunopharmacology, vol. 10, no. 8, pp. 959–966, 2010. View at Publisher · View at Google Scholar · View at Scopus
15. K. Tsoyi, H. B. Park, Y. M. Kim et al., “Anthocyanins from black soybean seed coats inhibit UVB-induced inflammatory cylooxygenase-2 gene expression and PGE2 production through regulation of the nuclear factor-κB and phosphatidylinositol 3-kinase/Akt pathway,” Journal of Agricultural and Food Chemistry, vol. 56, no. 19, pp. 8969–8974, 2008. View at Publisher · View at Google Scholar · View at Scopus
16. S. J. Park, W. H. Shin, J. W. Seo, and E. J. Kim, “Anthocyanins inhibit airway inflammation and hyperresponsiveness in a murine asthma model,” Food and Chemical Toxicology, vol. 45, no. 8, pp. 1459–1467, 2007. View at Publisher · View at Google Scholar · View at Scopus
17. A. Rossi, I. Serraino, P. Dugo et al., “Protective effects of anthocyanins from blackberry in a rat model of acute lung inflammation,” Free Radical Research, vol. 37, no. 8, pp. 891–900, 2003. View at Publisher · View at Google Scholar · View at Scopus
18. N. P. Seeram, R. A. Momin, M. G. Nair, and L. D. Bourquin, “Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries,” Phytomedicine, vol. 8, no. 5, pp. 362–369, 2001. View at Scopus
19. N. M. A. Hassimotto, M. I. Genovese, and F. M. Lajolo, “Identification and characterisation of anthocyanins from wild mulberry (Morus nigra L.) growing in Brazil,” Food Science and Technology International, vol. 13, no. 1, pp. 17–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
20. N. M. A. Hassimotto, M. I. Genovese, and F. M. Lajolo, “Absorption and metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from wild mulberry (Morus nigra L.) in rats,” Nutrition Research, vol. 28, no. 3, pp. 198–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
21. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
22. F. A. Fitzpatrick, “Cyclooxygenase enzymes: regulation and function,” Current Pharmacology Design, vol. 10, no. 6, pp. 577–588, 2004.
23. T. D. Warner and J. A. Mitchell, “Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic,” FASEB Journal, vol. 18, no. 7, pp. 790–804, 2004. View at Publisher · View at Google Scholar · View at Scopus
24. W. L. Smith, D. L. DeWitt, and R. M. Garavito, “Cyclooxygenases: structural, cellular, and molecular biology,” Annual Review of Biochemistry, vol. 69, pp. 145–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
25. H. R. Herschman, J. J. Talley, and R. DuBois, “Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging,” Molecular Imaging and Biology, vol. 5, no. 5, pp. 286–303, 2003. View at Publisher · View at Google Scholar · View at Scopus
26. J. P. Portanova, Y. Zhang, G. D. Anderson et al., “Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo,” Journal of Experimental Medicine, vol. 184, no. 3, pp. 883–891, 1996. View at Scopus
27. T. G. Brock and M. Peters-Golden, “Activation and regulation of cellular eicosanoid biosynthesis,” TheScientificWorldJournal, vol. 7, pp. 1273–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
28. N. V. Chandrasekharan, H. Dai, K. L. T. Roos et al., “COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13926–13931, 2002. View at Publisher · View at Google Scholar · View at Scopus
29. B. Kis, J. A. Snipes, T. Isse, K. Nagy, and D. W. Busija, “Putative cyclooxygenase-3 expression in rat brain cells,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 11, pp. 1287–1292, 2003. View at Scopus
30. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
31. J. S. Kang, Y. J. Jeon, S. K. Park, K. H. Yang, and H. M. Kim, “Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1β and prostaglandin E2 synthesis by silymarin,” Biochemical Pharmacology, vol. 67, no. 1, pp. 175–181, 2004. View at Publisher · View at Google Scholar · View at Scopus
32. Y. Bezugla, A. Kolada, S. Kamionka, B. Bernard, R. Scheibe, and P. Dieter, “COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages,” Prostaglandins and Other Lipid Mediators, vol. 79, no. 1-2, pp. 93–100, 2006. View at Publisher · View at Google Scholar · View at Scopus
33. P. Pradelles, J. Grassi, and J. Maclouf, “Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay,” Analytical Chemistry, vol. 57, no. 7, pp. 1170–1173, 1985. View at Scopus
34. O. M. E. Abdel-Salam, A. R. Baiuomy, S. El-batran, and M. S. Arbid, “Evaluation of the anti-inflammatory, anti-nociceptive and gastric effects of Ginkgo biloba in the rat,” Pharmacological Research, vol. 49, no. 2, pp. 133–142, 2004. View at Publisher · View at Google Scholar · View at Scopus
35. I. Posadas, M. Bucci, F. Roviezzo et al., “Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression,” British Journal of Pharmacology, vol. 142, no. 2, pp. 331–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
36. H. L. Malech and J. I. Gallin, “Current concepts: immunology—neutrophils in human diseases,” The New England Journal of Medicine, vol. 317, no. 11, pp. 687–694, 1987. View at Scopus
37. X. H. Jin, K. Ohgami, K. Shiratori et al., “Effects of blue honeysuckle (Lonicera caerulea L.) extract on lipopolysaccharide-induced inflammation in vitro and in vivo,” Experimental Eye Research, vol. 82, no. 5, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
38. K. J. Woo, Y. J. Jeong, H. Inoue, J. W. Park, and T. K. Kwon, “Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity,” FEBS Letters, vol. 579, no. 3, pp. 705–711, 2005. View at Publisher · View at Google Scholar · View at Scopus
39. J. C. Frölich, “A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes,” Trends in Pharmacological Sciences, vol. 18, no. 1, pp. 30–34, 1997. View at Publisher · View at Google Scholar · View at Scopus
40. J. A. Mitchell, P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane, “Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11693–11697, 1993. View at Publisher · View at Google Scholar · View at Scopus